Revance Therapeutics, Inc. Business Operations Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA, Revance Therapeutics, Inc. and Revance Australia Pty. Ltd
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
TN
2024
Sixth Amendment to the Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA and Revance Therapeutics, Inc
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Amendment No. 2 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated February 26, 2024, by and between Revance Therapeutics, Inc. and...
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Third Amendment to Exclusive Distribution Agreement dated December 22, 2022, by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Second Amendment to Exclusive Distribution Agreement, dated November 18, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated March 14, 2017 between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Commercial Supply Agreement, effective as of April 6, 2021, by and between Revance Therapeutics, Inc. and Lyophilization Services of New England, Inc
Supply Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2021
Amendment No. 1 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated December 18, 2020 between Revance Therapeutics, Inc. and Ajinomoto...
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
First Amendment to Exclusive Distribution Agreement
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Form of Voting Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein
Voting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Amendment #1 to the Collaboration and License Agreement dated August 22, 2019 between Revance Therapeutics, Inc. and Mylan Ireland Ltd
Collaboration Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
First Amendment to Manufacture and Development Agreement dated April 13, 2018 between the Company and Bachem Americas, Inc
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Collaboration and License Agreement by and between the Company and Mylan Ireland Ltd, dated as of February 28, 2018
Collaboration Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2018
Technology Transfer, Validation and Commercial Fill/Finish Services Agreement
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
REVANCE THERAPEUTICS, INC. $75,000,000 COMMONSTOCK SALES AGREEMENT
Sales Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2016
SECOND AMENDMENT to DEVELOPMENT AND SUPPLY AGREEMENT between REVANCE THERAPEUTICS, INC. and HOSPIRA WORLDWIDE, INC.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
FIRST AMENDMENT TO DEVELOPMENT, MANUFACTURING AND SUPPLY AGREEMENT ___________________________________
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN ADOPTED BY BOARD ON: AUGUST 29, 2014 AS AMENDED ON: SEPTEMBER 17, 2014 TERMINATION DATE: AUGUST 29, 2024
Termination Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN ADOPTED BY BOARD ON: AUGUST 26, 2014 TERMINATION DATE: AUGUST 26, 2024
Termination Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014